These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 28072660)

  • 1. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
    Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
    J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
    Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
    J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial magnetic stimulation during pregnancy.
    Hızlı Sayar G; Ozten E; Tufan E; Cerit C; Kağan G; Dilbaz N; Tarhan N
    Arch Womens Ment Health; 2014 Aug; 17(4):311-5. PubMed ID: 24248413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
    Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study of Accelerated Low-Frequency Right-Sided Transcranial Magnetic Stimulation for Treatment-Resistant Depression.
    Tor PC; Gálvez V; Goldstein J; George D; Loo CK
    J ECT; 2016 Sep; 32(3):180-2. PubMed ID: 26909825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT.
    Brunelin J; Jalenques I; Trojak B; Attal J; Szekely D; Gay A; Januel D; Haffen E; Schott-Pethelaz AM; Brault C; ; Poulet E
    Brain Stimul; 2014; 7(6):855-63. PubMed ID: 25192980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
    Blumberger DM; Mulsant BH; Fitzgerald PB; Rajji TK; Ravindran AV; Young LT; Levinson AJ; Daskalakis ZJ
    World J Biol Psychiatry; 2012 Sep; 13(6):423-35. PubMed ID: 21736507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder.
    Carpenter LL; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Stannard EL; Schneider MB
    Brain Stimul; 2017; 10(5):926-933. PubMed ID: 28642024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder.
    Wang YM; Li N; Yang LL; Song M; Shi L; Chen WH; Li SX; Wang XY; Lu L
    Psychiatry Res; 2017 Aug; 254():18-23. PubMed ID: 28441583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theta-patterned, frequency-modulated priming stimulation enhances low-frequency, right prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) in depression: a randomized, sham-controlled study.
    Nongpiur A; Sinha VK; Praharaj SK; Goyal N
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):348-57. PubMed ID: 21948897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.